Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director comp. Appointed director CC transcript
|
ENZO BIOCHEM INC (ENZ)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/31/2023 |
4
| Eckert Patricia (Interim CFO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 25,000 options to buy
@ $2.29, valued at
$57.3k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Cannon Kara (COO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 12,600 shares
@ $0 |
|
01/30/2023 |
4
| Wolf James G. (10% Owner) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Bought 11,800 shares
@ $1.4, valued at
$16.5k
|
|
01/23/2023 |
4
| Wolf James G. (10% Owner) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Converted 228,700 shares
@ $2.5, valued at
$571.8k
Converted 34,500 shares
@ $5, valued at
$172.5k
Converted 2,287 options to buy
@ $2.5, valued at
$5.7k
Converted 345 options to buy
@ $5, valued at
$1.7k
|
|
01/19/2023 |
4
| Wolf James G. (10% Owner) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Converted 300 shares
@ $2.5, valued at
$750 Converted 24,700 shares
@ $2.5, valued at
$61.8k
Converted 136,200 shares
@ $2.5, valued at
$340.5k
Converted 85,100 shares
@ $2.5, valued at
$212.8k
Converted 33,700 shares
@ $2.5, valued at
$84.3k
Bought 5,000 shares
@ $2.14, valued at
$10.7k
Bought 14,500 shares
@ $2.15, valued at
$31.2k
Bought 3,500 shares
@ $2.15, valued at
$7.5k
Bought 500 options to buy
@ $2.5, valued at
$1.3k
Sold 500 options to buy
@ $2.5, valued at
$1.3k
Sold 10 options to buy
@ $2.5, valued at
$25 |
|
11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/14/2022 |
4
| TAGLIAFERRI MARY (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 41,666 shares
@ $0 |
|
07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/14/2022 |
4
| Radoff Bradley Louis (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 41,666 shares
@ $0 |
|
07/13/2022 |
4
| Radoff Bradley Louis (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Bought 12,500 shares
@ $2.27, valued at
$28.4k
|
|
07/06/2022 |
4
| Radoff Bradley Louis (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Bought 120,000 shares
@ $2.2, valued at
$264k
|
|
06/17/2022 |
4
| Erfanian Hamid (CEO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Bought 4,600 shares
@ $2.19, valued at
$10.1k
Granted 700,000 options to buy
@ $3.39, valued at
$2.4M
|
|
06/16/2022 |
4
| Radoff Bradley Louis (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Bought 75,000 shares
@ $2.2, valued at
$165k
Bought 50,000 shares
@ $2.21, valued at
$110.5k
|
|
06/15/2022 |
4
| Bench David (CFO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Bought 3,500 shares
@ $2.15, valued at
$7.5k
|
|
04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2022 |
4
| Radoff Bradley Louis (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 39,063 shares
@ $0 |
|
04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2022 |
4
| Radoff Bradley Louis (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 30,000 shares
@ $2.91, valued at
$87.3k
|
|
04/14/2022 |
4
| Bench David (CFO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 1,620 shares
@ $2.9, valued at
$4.7k
Granted 880 shares
@ $2.9, valued at
$2.6k
|
|
04/14/2022 |
4
| Erfanian Hamid (CEO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 10,000 shares
@ $2.9, valued at
$29k
Granted 700,000 options to buy
@ $3.39, valued at
$2.4M
|
|
03/28/2022 |
4
| Cannon Kara (COO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 87,500 options to buy
@ $2.98, valued at
$260.8k
|
|
03/28/2022 |
4
| Bench David (CFO, SVP, Treasurer and CS) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 87,500 options to buy
@ $2.98, valued at
$260.8k
|
|
02/15/2022 |
4
| Bench David (CFO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 87,500 options to buy
@ $3.36, valued at
$294k
|
|
11/10/2021 |
4
| Erfanian Hamid (CEO) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 260,000 shares
@ $0 Granted 700,000 options to buy
@ $3.39, valued at
$2.4M
|
|
03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
4
| TAGLIAFERRI MARY (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 77,101 options to buy
@ $2.63, valued at
$202.8k
|
|
01/13/2021 |
4
| WEINER BARRY W (PRESIDENT AND TREASURER) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 142,586 shares
@ $0 |
|
01/13/2021 |
4
| Fischer Rebecca J. (Director) has filed a Form 4 on ENZO BIOCHEM INC
Txns:
| Granted 77,101 options to buy
@ $2.63, valued at
$202.8k
|
|
|
|
|